Rumor: Apple in Talks to Acquire Levels Health for $1.2B
Bloomberg reports Apple is in late-stage acquisition talks with Levels Health, the CGM software platform. Deal could close Q2 2026.
Not medical advice. This article reports on products and industry developments and is not a substitute for professional medical advice. Some links on this page are affiliate links — BioDataHQ may earn a commission at no extra cost to you. Medical disclaimer · Affiliate disclosure
Bloomberg reports that Apple is in advanced talks to acquire Levels Health, the continuous glucose monitoring software platform, for approximately $1.2 billion. The deal would bring Levels' metabolic health algorithms into Apple Health.
Strategic Rationale
Apple has spent over $1 billion developing non-invasive glucose monitoring for Apple Watch with limited success. Acquiring Levels would give Apple immediate access to 100,000+ CGM users and a proven software layer for glucose interpretation.
What Would Change
If the deal closes: Levels app would likely integrate with Apple Health. Current Levels members might transition to Apple Health+ subscription. Dexcom partnership (Levels uses Dexcom G7) could extend to Apple ecosystem.
Skepticism
This is a rumor, not confirmation. Apple rarely acquires consumer-facing brands. However, the company's glucose ambitions are well-documented and Levels' data could accelerate Apple's internal roadmap.